On our screens:Stocks with no debtCheap stocks by free cash flow yieldQuality compoundersQuality at a reasonable price
The financials
Merit Medical Systems, Inc. by the numbers
Merit Medical Systems, Inc. (MMSI) reported revenue of $382M in Q1 2026 (quarter ended Mar 31, 2026), up 7.5% from the same quarter a year earlier. That came with a gross margin of 48% and net income of $41M (11% of revenue). For the full year FY2025, revenue was $1.52B (+12% year on year) and net income $128M. Its largest product in Jun 2026 was Therapeutic at $138M, 35% of the disclosed total, well ahead of Foundational Original Equipment Manufacturer at 12%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $382M | $355M | +7.5% |
| Gross profit | $185M | $172M | +7.4% |
| Operating income | $44M | $41M | +7.6% |
| Net income | $41M | $30M | +36% |
| Diluted EPS | $0.68 | $0.49 | +39% |
| Product | Revenue | Share |
|---|---|---|
| Therapeutic | $138M | 35% |
| Foundational Original Equipment Manufacturer | $48M | 12% |
| Foundational Vascular Intervention | $42M | 11% |
| Therapeutic Vascular Intervention | $34M | 8.7% |
| Therapeutic Cardiac Therapies | $29M | 7.2% |
| Foundational Procedural Solutions | $28M | 7.1% |
| Therapeutic Oncology | $26M | 6.5% |
| Therapeutic Endoscopy | $24M | 6.0% |
| Therapeutic Original Equipment Manufacturer | $13M | 3.2% |
| Therapeutic Renal Therapies | $13M | 3.2% |
| Product And Service Other | $1.2M | 0.3% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $394.9M (+212%)
Product And Service Other grew +257% year on yearFoundational Procedural Solutions -12% year on year
Segment Latestquarter on quarteryear on year
- Therapeutic$137.9M$137.9MQoQ +9.1%year on year +15%+9.1%+15%
- Foundational Original Equipment Manufacturer$48.3M$48.3MQoQ -year on year +12%-+12%
- Foundational Vascular Intervention$41.7M$41.7MQoQ -year on year +19%-+19%
- Therapeutic Vascular Intervention$34.4M$34.4MQoQ -year on year +6.8%-+6.8%
- Therapeutic Cardiac Therapies$28.5M$28.5MQoQ -year on year +24%-+24%
- Foundational Procedural Solutions$27.9M$27.9MQoQ -year on year -12%--12%
- Therapeutic Oncology$25.8M$25.8MQoQ -year on year +7.6%-+7.6%
- Therapeutic Endoscopy$23.6M$23.6MQoQ -year on year +29%-+29%
- Therapeutic Original Equipment Manufacturer$12.8M$12.8MQoQ -year on year +31%-+31%
- Therapeutic Renal Therapies$12.7M$12.7MQoQ -year on year -0.81%--0.81%
- Product And Service Other$1.2M$1.2MQoQ -year on year +257%-+257%
Medical Instruments & Supplies
Ranks #14 of 19 by Smart Score